Vista Investment Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.33M Buy
29,128
+30
+0.1% +$6.45K 1.84% 12
2026
Q1
$6.33M Buy
29,098
+20
+0.1% +$4.44K 1.67% 12
2025
Q4
$6.64M Buy
29,078
+9
+0% +$2.05K 1.74% 11
2025
Q3
$6.73M Buy
29,069
+18
+0.1% +$3.67K 1.88% 13
2025
Q2
$5.39M Buy
29,051
+109
+0.4% +$20.3K 1.55% 18
2025
Q1
$6.06M Buy
28,942
+175
+0.6% +$34K 1.85% 11
2024
Q4
$5.11M Sell
28,767
-29
-0.1% -$5.33K 1.6% 17
2024
Q3
$5.69M Sell
28,796
-875
-3% -$163K 1.82% 14
2024
Q2
$5.09M Buy
29,671
+223
+0.8% +$36.9K 1.7% 13
2024
Q1
$5.36M Buy
29,448
+117
+0.4% +$20.2K 1.82% 13
2023
Q4
$4.55M Buy
+29,331
New +$4.28M 1.67% 16

Other funds holding ABBV

Vista Investment Partners's ABBV Position: Q2 2026 in Review

Vista Investment Partners increased its AbbVie (ABBV) stake by 0.1% in Q2 2026, buying an estimated $6.45K and bringing the position to 29,128 shares worth $7.33M. The position accounts for 1.84% of the portfolio, ranked #12.

Vista Investment Partners first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Vista Investment Partners held 29,128 shares of AbbVie worth $7.33M as of Q2 2026.
  • Vista Investment Partners bought 30 AbbVie shares in Q2 2026, an estimated $6.45K.
  • AbbVie made up 1.84% of Vista Investment Partners's portfolio in Q2 2026, its #12 holding.
  • Vista Investment Partners first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vista Investment Partners's 13F filing for Q2 2026, filed 9 Jul 2026.